A closer look at how local protein production is altered in ALS

The functioning of neurons, cells that transmit information in the nervous system, heavily relies on the production of ...
The Bakersfield Californian

NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a ...

The new CPT code reflects the latest efficacious medical care available to patients, facilitating adoption and utilization. The assignment of a Category I CPT® code demonstrates a strong message to ...
Business Insider

NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives

CARMEL, Ind., Dec. 19, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic ...
TechNode

AI is driving new content strategies and powering localization, but cultural understanding still depends on humans

Every Wednesday and Friday, TechNode’s Briefing newsletter delivers a roundup of the most important news in China tech, straight to your inbox. Sign up The Intelligent Futures: AI’s Global Ecosystems, ...
The National Law Review

NeurAxis Announces $5.0 Million Registered Direct Offering

CARMEL, Ind., May 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...
Business Insider

NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025

CARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...
GPS World

Building the future of localization: how GNSS+IMU and VPS work together

Your browser does not support the audio element. Accurate localization underpins modern mobility, powering everything from precise rideshare pickups and efficient ...
Seeking Alpha

NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population

Achieves significant expansion of NeurAxis’ total addressable market Clearance now includes patients aged “8 years and older” Expanded age indication will utilize the upcoming January 1 st, 2026, ...
Hosted on MSN

NeurAxis Expands Stock Offering to $6.27 Million

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. NeurAxis, Inc. ( (NRXS)) has issued an ...
Polygon

In the GOTY race, localization really matters — which is bad news for Blue Prince

The Game of the Year race has reached its tipping point. While we’ve had a clear-cut field of nominees for the bulk of 2025, September threw several wrenches into the conversation. With Hollow Knight: ...
NBC4 Columbus

NeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

CARMEL, Ind., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...